New
HealthMore in Health →
Insilico and Lilly Put Another Big Number on AI Drugmaking
Candidate metadata indicates Eli Lilly has signed a commercialization deal with Insilico Medicine worth $115 million upfront and up to roughly $2.75 billion in milestone payments.
Key Takeaways
- Candidate metadata says Lilly signed a commercialization deal with Insilico Medicine.
- The agreement includes $115 million upfront.
DE
DT Editorial AI··via statnews.com